Healthcare and life sciences in Switzerland

Bär & Karrer Ltd.

Bär & Karrer Ltd. is regularly instructed by national and international corporations, and impresses with a broad practice. In addition to being active in M&A and capital market transactions, disputes and regulatory matters, the team also advises on questions regarding drug distribution and marketing. Regulatory expert Markus Schott assists his clients in both contentious and non-contentious matters; he jointly leads the practice with Markus Wang, who specialises in IP. Philippe Seiler and Alexandra Johnson complement the team.

Practice head(s):

Markus Schott; Markus Wang

Key clients

Novartis

Sandoz

Vifor

Auven Therapeutics

Amgen

Losan

Helsinn

Glenmark

Sanofi

Novo Nordisk

Gedeon Richter

Lonza

Humabs Biomed

Work highlights

  • Advised Novartis and Alcon on the spin-off of Alcon as an independent, publicly traded company.
  • Assisted the purchaser of a clinic in the ophthalmology sector.
  • Provided the Health Department of the Canton of Zurich with an expert opinion regarding the dismissal of a physician.

CMS

CMS impresses with its broad coverage of work in the healthcare and life sciences field. The team is experienced in commercial cooperation agreements, financial benefits, comprehensive regulatory advice and compliance, as well as court and administrative proceedings. Patrick Sommer is well versed in merger control, parallel trade and clinical trials. Alain Raemy is noted for his expertise in healthcare law, and associate Marion Wyler is another key member of the team. Felix Kesselring left for Bratschi Ltd in early 2020.

Practice head(s):

Patrick Sommer

Testimonials

Good team for investing in early stage life science companies and the corporate group understands the key issues in the transactions.

Key clients

Synlab Suisse SA

Kieser Training AG

Syncona Investment Management Ltd.

Synlab International GmbH

Nextclinics International GmbH

Bayer (Switzerland) AG

Liva Nova Switzerland SA

Bruker Switzerland

Work highlights

  • Assisted Synlab International with the development and implementation of various compliance documents for Switzerland.
  • Acting for the Swiss branch of Bayer in the local administrative proceedings regarding price recommendations for ED Medications traded over-the-counter.
  • Advised Bruker on the acquisition of PMOD Technologies LLC.

Homburger

Homburger's life sciences practice fields specialists from the corporate, M&A, IP, competition and regulatory areas. It is often involved in significant transactions, proceedings and patent matters. The latter is a key area of expertise of Andri Hess, who is, together with Georg Rauber, the key contact in IP-related queries. Dieter Gericke is active in transactions, while Franz Hoffet and Marcel Dietrich cover competition, compliance and regulatory matters. Richard Stäuber and Luca Dal Molin made partner at the beginning of 2020.

Practice head(s):

Dieter Gericke; Marcel Dietrich; Georg Rauber

Key clients

Novartis

Johnson & Johnson

ChemChina

Syngenta

Eli Lilly

Sandoz

Google (Switzerland)

Nestlé

Illumina

Jefferies

Marle International

Molecular Partners

ADC Therapeutics

Santhera Pharmaceuticals Holding

Sensile

Spectris

swiss smile

Zur Rose Group

Work highlights

  • Represented Illumina in non-invasive prenatal testing (NIPT) patent enforcement and accompanying proceedings before the Swiss Federal Patent Court, among others.
  • Assisted Therachon with its sale to Pfizer and on the spin-off of Therachon’s Apraglutide programme.
  • Acting for Eli Lilly in an investigation concerning alleged vertical price fixing.

VISCHER

VISCHER has a strong track record in transactions in the life sciences space, in which it acts for companies, entrepreneurs and investors alike. It is also well versed in advising clients on compliance matters, administrative procedures and other regulatory matters. Stefan Kohler has longstanding experience in the sector and further advises on IP and technology law. He jointly leads the practice alongside Matthias Staehelin in Basel, who is a key contact for M&A, IPOs and financings in this space. Christian Wyss, also in Basel, has considerable knowledge in setting up contracts and assisting start-ups.

Practice head(s):

Stefan Kohler; Matthias Staehelin

Testimonials

Vischer has a strong commitment to support emerging life science companies and has a very good understanding of the specific needs, capabilities and limitations of these young firms.’

The firm provides services which are extremely robust and also cost-efficient for the client. It has the broadest experience and knowledge of the life sciences industry and can provide relevant advice based on its cultivated know-how. The firm stands out for its knowledge, accuracy, speed, integrity and customer focus.’

Matthias Staehelin is an excellent lawyer in all corporate and board matters.’

Christian Wyss stands out as an extremely knowledgable professional. He is always going beyond the basic requirements in order to understand his client’s needs and strives to see problems from their point of view. He takes extreme care to produce results which attend to the current and future needs of his clients.’

Key clients

Anaveon AG

Oculis SA

TransLink Capital

Azafaros B.V.

Numab Therapeutics AG

Mattern Pharma AG

Cibdol AG

Polyphor AG

AC Immune SA

Polares Medical SA

Dermedis Group

BACHEM HOLDING AG

Kuros Biosciences AG

ALENTIS Therapeutics

Polyneuron Pharmaceuticals AG

Urovant Sciences

Arvelle Therapeutics

Yonsung Pharmaceuticals

Drossapharm AG

Novo Nordisk

Work highlights

  • Acted for Anaveon in its CHF35m Series A financing round led by Syncona and joined by the Novartis Venture Fund.
  • Assisted Numab Therapeutics with entering into an exclusive regional licensing agreement with CStone Pharmaceuticals.
  • Represented Polyphor in a CHF6.8m capital increase with Novo REPAIR.

Baker McKenzie

Baker McKenzie is noted for its involvement in multi-jurisdictional mandates as well as its close collaboration across practice groups and offices. The team covers the gamut of healthcare and life sciences matters, including M&A, PE investments, licensing transactions, contracts, compliance and regulatory matters. Practice head Matthias Courvoisier specialises in capital market transactions. Other members of the team include Peter Reinert, who is well versed in competition, and international trade expert Serge Pannatier; both of them also advise on employment law. Eva-Maria Strobel is noted for her IP expertise.

Practice head(s):

Matthias Courvoisier

Key clients

Abbott

Abbvie

Actelion Pharmaceuticals AG

Baitella Holding AG

Baxalta Inc.

HBM Partners Ltd

Cell Medica Ltd

Sonova AG

Cosmo Pharmaceutical NV

Basilea Pharmaceutica AG

Cassiopea SpA

Sanofi Aventis (Suisse) SA

Celgene

The International Federation of Pharmaceutical Manufacturers & Associations

NLS Pharma AG

Curasept A.D.S. S.r.l.

Work highlights

  • Managing various of Abbott’s trademarks in Switzerland.
  • Advised the joint global coordinators and joint book runners, UBS and Morgan Stanley, on the rights offering to Zur Rose Group.
  • Assisted Cosmo Pharmaceuticals with its debt offering in the Eurobond markets.

BianchiSchwald LLC

BianchiSchwald LLC has a comprehensive offering in the healthcare sector. It counts companies and insurers as well as clinics and doctors among its clients, and the team advises on contractual negotiations, contentious matters and employment law. Marc Metzger is instructed on corporate and commercial mandates and he leads the practice jointly with finance expert Thomas Goossens in Geneva. Thomas Schmid is another key contact.

Practice head(s):

Marc Metzger; Thomas Goosens

Key clients

VAMED Management und Service Schweiz AG, Zihlschlacht-Sitterdorf

Rehaklinik Zihlschlacht AG, Zihlschlacht-Sitterdorf

VAMED Health Project Schweiz AG, Zihlschlacht-Sitterdorf

Prexton Therapeutics SA

Calypso Biotech SA

Correvio International Sàrl

Rehaklinik Dussnang AG

Reha Seewis AG

Work highlights

  • Assisting Rehaklinik Dussnang in connection with the construction of a rehabilitation clinic in Switzerland.
  • Acting as legal counsel for Prexton Therapeutics and Calypso Biotech.
  • Advised Cardiome International on corporate and contractual matters.

Kellerhals Carrard

Kellerhals Carrard has a strong track record in representing clients from the healthcare and life sciences sector in disputes, particularly product liability-related, and in competition and contract law. Another pillar of the practice is assisting clients in regulatory matters, as well as in financing and M&A. Thomas Eichenberger, based in Bern, is the team leader; he is experienced in the areas of health, pharmaceuticals, and medical devices. >Claudia Götz Staehelin in Basel is a key practitioner in investigations and litigation. Lausanne-based Jean-Luc Chenaux is also noted.

Practice head(s):

Thomas Eichenberger

Testimonials

Kellerhals Carrard delivers a very high quality of legal advice and has excellent litigation know-how. The team has excellent accessibility also on short notice and consists of nice and down-to-earth style of the whole team.’

Claudia Götz Staehelin has unrivalled experience as former Head of Litigation at Novartis. She’s a superb lawyer with a quick mind and an always reliable judgement.’

Key clients

Interpharma

F. Hoffmann-La Roche AG

Bayer AG

KPT Versicherungen AG

Health Sciences e-Training Foundation

Gilead Sciences Switzerland Sàrl

Visana Services AG

Blutspende SRK AG (Swiss Red Cross)

Amazentis SA

Work highlights

  • Represented members of Interpharma in litigation regarding inadmissible price reductions.
  • Assisted KPT Versicherungen regarding the reimbursement of out-of-canton elective medical treatments.
  • Advised Amazentis in several private equity rounds.

Lenz & Staehelin

The healthcare and life sciences team at Lenz & Staehelin includes practitioners from the corporate, M&A, regulatory, dispute resolution and IP practices. It advises national and international companies from the pharmaceuticals, biotechnology and medical devices sectors, among others. The key practitioners are patent experts Thierry Calame and counsel Lara Dorigo; transactions specialist Stephan ErniJacques Iffland in Geneva, who is experienced in capital markets; and litigation and arbitration expert Harold Frey.

Practice head(s):

Thierry Calame; Stephan Erni; Jacques Iffland; Guy Vermeil

Testimonials

The team has good communication, great strategy, and straightforward billing.’

Thierry Calame is an excellent advocate who gets tremendous results.

Lara Dorigo stands out for know-how, dedication, creativity, and her ‘make-it-happen’ philosophy.’

Key clients

ALPHA Healthgroup

Bayer

COLTENE Holding AG

Emergent BioSolutions Inc.

Hirslanden Group of Hospitals

Johnson & Johnson

Lesaffre

Mepha

MEDA Pharma

Merck Serono

Novo Holding A/S

MSD Merck Sharp & Dohme; Merck & Co. Inc.

ObsEva

Pfizer

Portola Pharmaceuticals, Inc.

Sanofi

Siemens

Teva Pharma AG

Unilabs, Laboratoire d’analyses médicales SA

Work highlights

  • Advised NovImmune on the sale of its Emapalumab business to Novartis.
  • Assisted ObsEva with its share capital increase.
  • Representing Mepha/Teva as plaintiff in patent nullity proceedings involving several patents in relation to breast cancer treatment.

Mangeat Attorneys at Law LLC

Mangeat Attorneys at Law LLC's team acts for medical device manufacturers and life sciences companies as well as healthcare institutions and professionals. In addition to handling corporate and commercial work in this space, it is also noted for its involvement in malpractice cases and other disputes; Grégoire Mangeat and counsel Sara Dousset are the key contacts for these cases. Fabien Aepli is well versed in commercial contracts and licence agreements.

Practice head(s):

Fabien Aepli; Sara Dousset

Work highlights

  • Representing a medical devices manufacturer in civil proceedings against a former distributor claiming compensation for breach of the distribution agreement.

Meyerlustenberger Lachenal Ltd

Meyerlustenberger Lachenal Ltd covers M&A, product liability and regulatory matters, with particular expertise in patent litigation, data protection and e-health. Team leader Simon Holzer and Michael Ritscher are experts in IP disputes. Kilian Schärli is a key contact in blockchain pharmaceutical use matters. Ulrike Ciesla joined in February 2019 from Hoffmann Eitle.

Practice head(s):

Simon Holzer

Testimonials

MLL offers excellent integrated legal advice in a broad range of legal fields.’

The team is enormously experienced in all matters of pharma IP litigation.

Simon Holzer stands out from competitors due to his commercial way of thinking – naturally combined with great legal skills, making his advice trustworthy and helpful for his client’s business.’

Michael Ritscher is a senior partner in the pharm IP team. He is extremely experienced, knowledgeable and has excellent knowledge of the pharmaceutical sector.’

Ulrike Ciesla is an excellent patent attorney and advocate. She brings real strength to the team.’

Kilian Schärli has excellent legal know-how and is highly appreciated for his can-do approach. He is further highly committed and always offers pragmatic solutions for his clients.’

Key clients

AstraZeneca AB

Bayer

Bioeq IP AG

Carestream

Cereneo AG

CHOCOSUISSE

Eli Lilly

Gilead Sciences, Inc.

H. Lundbeck A/S (Denmark); Lundbeck Schweiz AG

Kantonsspital St. Gallen (KSSG)

Modum

Mundipharma

Spital Männedorf AG

Swiss Cosmetic Association (SKW)

ViiV Healthcare UK Limited

Visiomed Laboratorie

Work highlights

  • Representing Gilead in proceedings regarding the validity and the scope of an SPC for a combination product.
  • Acting for Mundipharma in several related disputes concerning patents protecting its drug Targin®.
  • Assisted Modum regarding a blockchain pharmaceutical use case in its supply chain.

Pestalozzi

Pestalozzi focuses on regulatory, litigation, product liability and corporate matters, and the team is also increasingly involved in acquisitions and asset purchases and divestitures. It is experienced in working for international life sciences companies. The practice is led by trade and employment specialist Christian RoosFranz Schubiger and Florian Mohs are further key practitioners. Lorenza Ferrari Hofer left the firm in 2020.

Practice head(s):

Christian Roos

Key clients

Johnson & Johnson

Zimmer Biomet

University Hospital Zurich(USZ)

Ivoclar Vivadent

Astellas Pharma Europe

GE Healthcare

Promethera Biosciences SA

Gilead / Kite Pharma

Merck KGaA

Recordati Rare Diseases

Akorn Pharma

Intercos Sp

Work highlights

  • Assisted Recordati with the licensing and regulatory aspects of a license agreement between its group company Orphan Europe and Helsin.
  • Represented Anandic Medical Systems in a public procurement law dispute concerning the delivery of Patient Monitoring Systems (PMS) to the Ente Ospidaliero Cantonale of the canton of Ticino.
  • Assisted a biotech company with the legal integration work in Switzerland following its acquisition of another company.

Schellenberg Wittmer Ltd

Schellenberg Wittmer Ltd impresses with a strong dispute resolution practice in the life sciences sector, with expertise in patent validity and infringement, product liability and manufacturing, distribution and clinical trial agreements. The team is further active in the transactional and regulatory space. Practice head Philipp Groz also leads the firm's IP group and is an expert in contentious matters. Professor of law Peter Georg Picht supports the team since the end of 2018 as of counsel. Lorenza Ferrari Hofer  was a new arrival in September 2020.

Practice head(s):

Philipp Groz

Testimonials

The team has strong abilities in dealing with international matters. It works transparently and reliably for the best possible outcome supported by its strong legal knowledge and assessment capabilities.

SW combines very good understanding of the regulatory issues with great litigation skills.’

Philipp Groz is a very dedicated, hard-working and skilled lawyer. He is consistently helpful, very responsible and provides clients with high quality, perfectly prepared pieces of legal work.’

Key clients

Catalent Pharma Solutions

Merck Serono

Santhera Pharmaceuticals

Quark Pharmaceuticals

Cardinal Health

Bayer AG

Bioton S.A.

Sunovion Pharmaceuticals

CSL Behring AG

Ascensia Diabetes Care

Sun Chemicals

Addlife AB

Shire International GmbH

Scientis SA

Procter & Gamble

Celgene

Ascencia Diabetes Care

LivaNova

AOP Orphan Pharmaceuticals AG

Work highlights

  • Assisted Santhera with several multi-jurisdictional licensing deals.
  • Representing a medical device company in the Swiss part of global product liability litigation relating to its drug allegedly resulting in personal injury and death.
  • Advised a pharmaceutical group specialising in medical aesthetics on a clinical trial agreement for trials to be conducted in Switzerland.

Walder Wyss Ltd.

The team at Walder Wyss Ltd. has a good track record in litigation mandates in the healthcare and life sciences sector; it is particularly active in reimbursement and pricing cases, as well as in patent proceedings, which is the area of expertise of Markus Frick. Practice head Andreas Wildi is based in Bern and specialises in matters relating to international reimbursement and pricing law. Alexander Gutman in Basel has expertise in corporate law and M&A in the life sciences field.

Practice head(s):

Andreas Wildi

Key clients

Pfizer

Biogen

Wenger & Vieli LTD

International pharmaceutical and medical devices companies, as well as mid-sized entities and start-ups instruct Wenger & Vieli LTD on transactions, life sciences law queries and pricing and reimbursement matters. Department head Frank Scherrer knows the latter area particularly well, in addition to having expertise in marketing authorisations, data protection and competition law. Beat Speck in Zug is the firm's key contact in M&A and private equity transactions in the field. Associates Marcel Boller and Andrea Schütz are also key members of the team.

Practice head(s):

Frank Scherrer

Work highlights

  • Represented different pharmaceutical companies in appeals against price decrease decisions of the Federal Office of Public Health.
  • Involved in several private equity deals regarding life sciences companies.
  • Acting for a pharmaceutical company in multiple product liability lawsuits regarding one of its products.